neostigmine methylsulfate

FDA Drug Profile — NEOSTIGMINE METHYLSULFATE, neostigmine methylsulfate

neostigmine methylsulfate is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand names including NEOSTIGMINE METHYLSULFATE, neostigmine methylsulfate. Available dosage form: injection.

Drug details

Generic Name
neostigmine methylsulfate
Brand Names
NEOSTIGMINE METHYLSULFATE, neostigmine methylsulfate
Application Number
ANDA209933
Sponsor
Amphastar Pharmaceuticals, Inc.
NDC Codes
7
Dosage Forms
INJECTION
Routes
INTRAVENOUS
Active Ingredients
NEOSTIGMINE METHYLSULFATE

Indications and Usage

1. INDICATIONS AND USAGE Neostigmine Methylsulfate Injection, USP is a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. Neostigmine Methylsulfate Injection, USP, a cholinesterase inhibitor, is indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.